Industry: Service & Software
Published Date: 2025-06-14
Pages: 89 Pages
Report ld: 4765039
Request Sample
Customized Report
Biomanufacturing Platform Market Size(US$)

CAGR 2025-2031
23.6%
Market Size,2031
USD 1,425
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Biomanufacturing Platform was valued at US$ 328 million in the year 2024 and is projected to reach a revised size of US$ 1425 million by 2031, growing at a CAGR of 23.6% during the forecast period.
Biomanufacturing refers to a manufacturing method that uses organisms or their mechanisms (such as cells, microorganisms, viruses, etc.) to synthesize products or promote production processes on an industrial scale. It is widely used in the fields of medicine, food, chemicals, materials, etc. It replaces traditional petrochemical routes to achieve more efficient and sustainable production, and is becoming an important support for global green transformation and high value-added innovation.
Biomanufacturing Platform refers to an integrated and scalable industrial solution system that supports the entire process of biological products (such as antibodies, vaccines, cell and gene therapies, mRNA, fermentation metabolites, etc.) from early research and development, process development, pilot verification to GMP commercial production.
North American market for Biomanufacturing Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomanufacturing Platform is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomanufacturing Platform in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomanufacturing Platform include Biotechnet, BioFactura, Evotec, Xcellerex, Manus Bio Inc., Batavia Biosciences, Samabriva, LFB biomanufacturing, Arsenale Bioyards Srl, EnginZyme, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomanufacturing Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomanufacturing Platform.
The Biomanufacturing Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomanufacturing Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomanufacturing Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomanufacturing Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomanufacturing Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Clinical Manufacturing
1.2.3 Upscaling
1.2.4 Commercial Manufacturing
1.3 Market by Application
1.3.1 Global Biomanufacturing Platform Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Agriculture
1.3.4 Energy
1.3.5 Food
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomanufacturing Platform Market Perspective (2020-2031)
2.2 Global Biomanufacturing Platform Growth Trends by Region
2.2.1 Global Biomanufacturing Platform Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomanufacturing Platform Historic Market Size by Region (2020-2025)
2.2.3 Biomanufacturing Platform Forecasted Market Size by Region (2026-2031)
2.3 Biomanufacturing Platform Market Dynamics
2.3.1 Biomanufacturing Platform Industry Trends
2.3.2 Biomanufacturing Platform Market Drivers
2.3.3 Biomanufacturing Platform Market Challenges
2.3.4 Biomanufacturing Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomanufacturing Platform Players by Revenue
3.1.1 Global Top Biomanufacturing Platform Players by Revenue (2020-2025)
3.1.2 Global Biomanufacturing Platform Revenue Market Share by Players (2020-2025)
3.2 Global Top Biomanufacturing Platform Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomanufacturing Platform Revenue
3.4 Global Biomanufacturing Platform Market Concentration Ratio
3.4.1 Global Biomanufacturing Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomanufacturing Platform Revenue in 2024
3.5 Global Key Players of Biomanufacturing Platform Head office and Area Served
3.6 Global Key Players of Biomanufacturing Platform, Product and Application
3.7 Global Key Players of Biomanufacturing Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomanufacturing Platform Breakdown Data by Type
4.1 Global Biomanufacturing Platform Historic Market Size by Type (2020-2025)
4.2 Global Biomanufacturing Platform Forecasted Market Size by Type (2026-2031)
5 Biomanufacturing Platform Breakdown Data by Application
5.1 Global Biomanufacturing Platform Historic Market Size by Application (2020-2025)
5.2 Global Biomanufacturing Platform Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomanufacturing Platform Market Size (2020-2031)
6.2 North America Biomanufacturing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomanufacturing Platform Market Size by Country (2020-2025)
6.4 North America Biomanufacturing Platform Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomanufacturing Platform Market Size (2020-2031)
7.2 Europe Biomanufacturing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomanufacturing Platform Market Size by Country (2020-2025)
7.4 Europe Biomanufacturing Platform Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomanufacturing Platform Market Size (2020-2031)
8.2 Asia-Pacific Biomanufacturing Platform Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomanufacturing Platform Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomanufacturing Platform Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomanufacturing Platform Market Size (2020-2031)
9.2 Latin America Biomanufacturing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomanufacturing Platform Market Size by Country (2020-2025)
9.4 Latin America Biomanufacturing Platform Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomanufacturing Platform Market Size (2020-2031)
10.2 Middle East & Africa Biomanufacturing Platform Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomanufacturing Platform Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomanufacturing Platform Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotechnet
11.1.1 Biotechnet Company Details
11.1.2 Biotechnet Business Overview
11.1.3 Biotechnet Biomanufacturing Platform Introduction
11.1.4 Biotechnet Revenue in Biomanufacturing Platform Business (2020-2025)
11.1.5 Biotechnet Recent Development
11.2 BioFactura
11.2.1 BioFactura Company Details
11.2.2 BioFactura Business Overview
11.2.3 BioFactura Biomanufacturing Platform Introduction
11.2.4 BioFactura Revenue in Biomanufacturing Platform Business (2020-2025)
11.2.5 BioFactura Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Biomanufacturing Platform Introduction
11.3.4 Evotec Revenue in Biomanufacturing Platform Business (2020-2025)
11.3.5 Evotec Recent Development
11.4 Xcellerex
11.4.1 Xcellerex Company Details
11.4.2 Xcellerex Business Overview
11.4.3 Xcellerex Biomanufacturing Platform Introduction
11.4.4 Xcellerex Revenue in Biomanufacturing Platform Business (2020-2025)
11.4.5 Xcellerex Recent Development
11.5 Manus Bio Inc.
11.5.1 Manus Bio Inc. Company Details
11.5.2 Manus Bio Inc. Business Overview
11.5.3 Manus Bio Inc. Biomanufacturing Platform Introduction
11.5.4 Manus Bio Inc. Revenue in Biomanufacturing Platform Business (2020-2025)
11.5.5 Manus Bio Inc. Recent Development
11.6 Batavia Biosciences
11.6.1 Batavia Biosciences Company Details
11.6.2 Batavia Biosciences Business Overview
11.6.3 Batavia Biosciences Biomanufacturing Platform Introduction
11.6.4 Batavia Biosciences Revenue in Biomanufacturing Platform Business (2020-2025)
11.6.5 Batavia Biosciences Recent Development
11.7 Samabriva
11.7.1 Samabriva Company Details
11.7.2 Samabriva Business Overview
11.7.3 Samabriva Biomanufacturing Platform Introduction
11.7.4 Samabriva Revenue in Biomanufacturing Platform Business (2020-2025)
11.7.5 Samabriva Recent Development
11.8 LFB biomanufacturing
11.8.1 LFB biomanufacturing Company Details
11.8.2 LFB biomanufacturing Business Overview
11.8.3 LFB biomanufacturing Biomanufacturing Platform Introduction
11.8.4 LFB biomanufacturing Revenue in Biomanufacturing Platform Business (2020-2025)
11.8.5 LFB biomanufacturing Recent Development
11.9 Arsenale Bioyards Srl
11.9.1 Arsenale Bioyards Srl Company Details
11.9.2 Arsenale Bioyards Srl Business Overview
11.9.3 Arsenale Bioyards Srl Biomanufacturing Platform Introduction
11.9.4 Arsenale Bioyards Srl Revenue in Biomanufacturing Platform Business (2020-2025)
11.9.5 Arsenale Bioyards Srl Recent Development
11.10 EnginZyme
11.10.1 EnginZyme Company Details
11.10.2 EnginZyme Business Overview
11.10.3 EnginZyme Biomanufacturing Platform Introduction
11.10.4 EnginZyme Revenue in Biomanufacturing Platform Business (2020-2025)
11.10.5 EnginZyme Recent Development
11.11 Alpine Bio
11.11.1 Alpine Bio Company Details
11.11.2 Alpine Bio Business Overview
11.11.3 Alpine Bio Biomanufacturing Platform Introduction
11.11.4 Alpine Bio Revenue in Biomanufacturing Platform Business (2020-2025)
11.11.5 Alpine Bio Recent Development
11.12 Bio Base Europe Pilot Plant
11.12.1 Bio Base Europe Pilot Plant Company Details
11.12.2 Bio Base Europe Pilot Plant Business Overview
11.12.3 Bio Base Europe Pilot Plant Biomanufacturing Platform Introduction
11.12.4 Bio Base Europe Pilot Plant Revenue in Biomanufacturing Platform Business (2020-2025)
11.12.5 Bio Base Europe Pilot Plant Recent Development
11.13 Merck KGaA
11.13.1 Merck KGaA Company Details
11.13.2 Merck KGaA Business Overview
11.13.3 Merck KGaA Biomanufacturing Platform Introduction
11.13.4 Merck KGaA Revenue in Biomanufacturing Platform Business (2020-2025)
11.13.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biomanufacturing Platform market is projected to grow from US$ 400 million in 2025 to US$ 1727 million by 2032, at a CAGR of 23.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 134
USD 4900.00
(Single User License)
The global Biomanufacturing Platform market size was US$ 400 million in 2025 and is forecast to reach a readjusted size of US$ 1727 million by 2032 with a CAGR of 23.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 97
USD 4250.00
(Single User License)
The global Biomanufacturing Platform market was valued at US$ 400 million in 2025 and is anticipated to reach US$ 1727 million by 2032, at a CAGR of 23.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 111
USD 2900.00
(Single User License)
The global market for Biomanufacturing Platform was estimated to be worth US$ 400 million in 2025 and is projected to reach US$ 1727 million, growing at a CAGR of 23.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 113
USD 3950.00
(Single User License)
The global Biomanufacturing Platform market size was US$ 328 million in 2024 and is forecast to a readjusted size of US$ 1425 million by 2031 with a CAGR of 23.6% during the forecast period 2025-2031.
Published Date: 2025-06-14
Pages: 93
USD 4250.00
(Single User License)
The global market for Biomanufacturing Platform was estimated to be worth US$ 328 million in 2024 and is forecast to a readjusted size of US$ 1425 million by 2031 with a CAGR of 23.6% during the forecast period 2025-2031.
Published Date: 2025-06-14
Pages: 105
USD 3950.00
(Single User License)
The global Biomanufacturing Platform market is projected to grow from US$ 400 million in 2025 to US$ 1425 million by 2031, at a Compound Annual Growth Rate (CAGR) of 23.6% during the forecast period.
Published Date: 2025-06-14
Pages: 139
USD 4900.00
(Single User License)
The global Biomanufacturing Platform market is projected to grow from US$ 400 million in 2025 to US$ 1727 million by 2032, at a CAGR of 23.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 134
The global Biomanufacturing Platform market size was US$ 400 million in 2025 and is forecast to reach a readjusted size of US$ 1727 million by 2032 with a CAGR of 23.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 97
The global Biomanufacturing Platform market was valued at US$ 400 million in 2025 and is anticipated to reach US$ 1727 million by 2032, at a CAGR of 23.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 111
The global market for Biomanufacturing Platform was estimated to be worth US$ 400 million in 2025 and is projected to reach US$ 1727 million, growing at a CAGR of 23.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 113
The global Biomanufacturing Platform market size was US$ 328 million in 2024 and is forecast to a readjusted size of US$ 1425 million by 2031 with a CAGR of 23.6% during the forecast period 2025-2031.
Published: 2025-06-14
Pages: 93
The global market for Biomanufacturing Platform was estimated to be worth US$ 328 million in 2024 and is forecast to a readjusted size of US$ 1425 million by 2031 with a CAGR of 23.6% during the forecast period 2025-2031.
Published: 2025-06-14
Pages: 105
The global Biomanufacturing Platform market is projected to grow from US$ 400 million in 2025 to US$ 1425 million by 2031, at a Compound Annual Growth Rate (CAGR) of 23.6% during the forecast period.
Published: 2025-06-14
Pages: 139
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now